Reversal of P‐glycoprotein‐mediated multidrug resistance by natural N ‐alkylated indole alkaloid derivatives in KB‐ChR‐8‐5 drug‐resistant cancer cells
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Pradhapsingh Bharathiraja und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar, Tamil Nadu, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Alkaloids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: RUSA 2.0, Annamalai University, Fundação para a Ciência e a Tecnologia (FCT).
Abstract (Originalsprache)
Multidrug resistance (MDR) remains a significant challenge in cancer chemotherapy due to the overexpression of ATP‐binding cassette drug‐efflux transporters, namely P‐glycoprotein (P‐gp)/ATP‐binding cassette subfamily B member 1. In this study, derivatives of N ‐alkylated monoterpene indole alkaloids such as N ‐( para ‐bromobenzyl) (NBBT), N ‐( para ‐methylbenzyl) (NMBT), and N ‐( para ‐methoxyphenethyl) (NMPT) moieties were investigated for the reversal of P‐gp‐mediated MDR in drug‐resistant KB colchicine‐resistant 8‐5 (KB‐ChR‐8‐5) cells. Among the three indole alkaloid derivatives, the NBBT exhibited the highest P‐gp inhibitory activity in a dose‐dependent manner. Further, it significantly decreased P‐gp overexpression by inactivating the nuclear translocation of the nuclear factor kappa B p‐50 subunit. In the cell survival assay, doxorubicin showed 6.3‐fold resistance (FR) in KB‐ChR‐8‐5 cells compared with its parental KB‐3‐1 cells. However, NBBT significantly reduced doxorubicin FR to 1.7, 1.3, and 0.4 and showed strong synergism with doxorubicin for all the concentrations studied in the drug‐resistant cells. Furthermore, NBBT and doxorubicin combination decreased the cellular migration and showed increased apoptotic incidence by downregulating Bcl‐2, then activating BAX, caspase 3, and p53. The present findings suggest that NBBT could be a lead candidate for the reversal of P‐gp‐ mediated multidrug resistance in cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar, Tamil Nadu, India.
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
- Centro de Estudos Moçambicanos e de Etnociências (CEMEC), Faculdade de Ciências Naturais e Matemática, Universidade Pedagógica Campus de Lhanguene, Maputo, Moçambique.
Förderung
- RUSA 2.0, Annamalai University
- Fundação para a Ciência e a Tecnologia (FCT)
Zitieren
APA
Bharathiraja, P., Cardoso, D. S. P., Rajendra Prasad, N., Mulhovo, S., Lakra, D. S., & Ferreira, M. U. (2023). Reversal of P‐glycoprotein‐mediated multidrug resistance by natural N ‐alkylated indole alkaloid derivatives in KB‐ChR‐8‐5 drug‐resistant cancer cells. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23421
Vancouver
Bharathiraja P, Cardoso DSP, Rajendra Prasad N, Mulhovo S, Lakra DS, Ferreira MU. Reversal of P‐glycoprotein‐mediated multidrug resistance by natural N ‐alkylated indole alkaloid derivatives in KB‐ChR‐8‐5 drug‐resistant cancer cells. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23421
BibTeX
@article{Bharathiraja2023,
author = {Bharathiraja, Pradhapsingh and Cardoso, David S P and Rajendra Prasad, N and Mulhovo, Silva and Lakra, Deepa S and Ferreira, Maria-José U},
title = {Reversal of P‐glycoprotein‐mediated multidrug resistance by natural N ‐alkylated indole alkaloid derivatives in KB‐ChR‐8‐5 drug‐resistant cancer cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23421}
}
EUVIMED